NIH-funded research R01 grant

Investigating how certain bacteria and proteins contribute to colorectal cancer

Official title: Microbial and host biomarkers in colorectal cancer oncogenesis

Funded at Columbia University Health Sciences · NIH-11133253 · Data updated 2026-11-12

This study is looking at how a specific bacteria and a protein in the body might work together to influence the growth of colorectal cancer, especially when the body is under stress, with the goal of finding new ways to diagnose and treat this type of cancer.

More Colorectal Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$600,499
NIH project number1R01CA292464-01A1
Project IDNIH-11133253 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for colorectal cancer or those diagnosed with the disease.

Less likely to help

Patients with colorectal cancer who do not have the specific bacterial or protein markers being studied may not benefit from this research.

What this research studies

This research focuses on understanding the role of Fusobacterium nucleatum, a type of bacteria, and a protein called Annexin A1 in the development of colorectal cancer. The study aims to explore how these factors interact and contribute to cancer growth, particularly under stress conditions. By examining the biochemical changes in these components, the researchers hope to identify new biomarkers that could help in diagnosing and treating colorectal cancer more effectively.

Why it matters

Potential benefit: If successful, this research could lead to new diagnostic tools and therapies for colorectal cancer, improving patient outcomes.

How similar studies have gone: Previous research has shown promising results in understanding the role of microbes in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Han, Yiping — Columbia University Health Sciences
  • Study coordinator: Han, Yiping

Related research

Other NIH-funded projects on the same topics.

  • Improving colorectal cancer screening and follow-up care.

    This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.

    NIH research Research Triangle Institute · Research Triangle Park, United States · NIH-9627071

  • Colorectal cancer prognosis through a broad, collaborative study

    A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11590756

  • Ceramides and how they affect metabolism and colorectal cancer in adults

    A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11535283

  • Automated point-of-care DNA methylation test for colorectal cancer in LMICs

    A fast, affordable blood test using DNA markers to help identify people at higher risk of colorectal cancer in low- and middle-income countries.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11531863

  • Rewiring Colorectal Cancer to Harness Therapeutic Hyperactivation

    A Yale team is exploring brain-storming new ways to treat colorectal cancer by safely boosting certain cancer signaling pathways to kill cancer cells and by reshaping cancer cell states to improve responses to existing therapies.

    NIH research Yale University · New Haven, United States · NIH-11505210

  • Comparative modeling to guide colorectal cancer screening and care

    A researcher team will use computer models to study how access to care, risk, and new screening options affect colorectal cancer outcomes and costs for adults in the US.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11495363

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.